HSPG2 and hepatocellular carcinoma: The results showed that inhibiting the expression of RHOT1 and RAC1 in Lv-HMGB1 PLC cells could reduce the mitochondrial transfer, the migration and invasion ability of HCC cells, and the in vivo tail vein lung metastasis ability (Fig. 6k–o).